About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, December 9th, 2013

The QualityStocks
Daily Stock List

graphic
graphic

OncoSec Medical, Inc. (ONCS)

PennyStocks24, Stock Analyzer, Greenbackers, and Real Pennies reported earlier on OncoSec Medical, Inc. (ONCS), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OncoSec Medical, Inc. is an OTCQB-listed biopharmaceutical company. The Company is developing their advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors. OncoSec’s mission is to pioneer and refine new electroporation technologies that endeavor to benefit patients and improve the quality of life for those whose skin cancers cannot be treated effectively with conventional treatment approaches. The Company’s clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers.  OncoSec Medical is based in San Diego, California.

The Company’s ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution for less invasive and less expensive therapies that can reduce detrimental effects resulting from presently available cancer treatments. These presently available treatments include surgery, systemic chemotherapy, or immunotherapy and other treatment alternatives.

The basis of OncoSec’s core technology is upon their proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these targeted anti-cancer agents has demonstrated selective destruction of cancerous cells. This is while potentially sparing healthy normal tissues during early and late stage clinical trials.

OncoSec Medical announced this past October positive preliminary animal data demonstrating the benefits of combining their ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies. Dr. Richard Heller, professor at Old Dominion University, summarized the initial results of this study at the Cancer Vaccines and Gene Therapy Meeting in Philadelphia, Pennsylvania. The study took place using a single tumor model; 40 mice (eight treatment groups) were treated with either ImmunoPulse alone, or in combination with anti-CTLA4, anti-PD1 or both at varying concentrations.

Results indicate that all treatment groups showed 100 percent regression of treated lesions in all mice, and that no mice died as a result of toxicity from treatment. The results from this initial study demonstrate that ImmunoPulse in combination with anti-CTLA4 or anti-PD1 is safe, effective, and does not have any contraindicated outcomes. Based on these positive results, OncoSec Medical’s intention is to continue testing combination approaches in more aggressive melanoma models that will support additional evaluation of this approach in humans.

In addition, in October, OncoSec Medical published a new blog post on The Chairman's Blog, written by the Company's President and CEO, Punit Dhillon. TheChairmansBlog.com is an exclusive online media publication. It allows key executive officers a unique platform to share insights about their company and industry trends.

In the post, Mr. Dhillon wrote about the vision behind OncoSec Medical’s sponsored research agreement with Old Dominion University and the Frank Reidy Research Center for Bioelectrics to initiate a combination study for the development of a new cancer treatment. Mr. Dhillon wrote that, in the combination study, OncoSec sees an "opportunity to increase response rates and overall effectiveness [of treatment]."

OncoSec Medical, Inc. (ONCS), closed Monday's trading session at $0.307, up 2.33%, on 877,224 volume with 133 trades. The average volume for the last 60 days is 2,093,496 and the stock's 52-week low/high is $0.182/$0.364.

Paradigm Resource Management Corp. (PRDC)

VipStockReports and Pinnacle Stock Alerts reported today on Paradigm Resource Management Corp. (PRDC), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Paradigm Resource Management Corp. is an investment company that lists on the OTC Markets’ OTCQB. The Company’s goal is to become a platform for global investors to invest in the development and operations of companies within the mining industry with a special focus on new technology and applied materials. The expectation is that investments will be chiefly in the form of equity; however, investments may be in debt, convertible securities or investments in specific projects. Paradigm Resource Management has their corporate headquarters in San Mateo, California.

The Company’s intention is to invest in industries with high growth potential. Investment targets include the Pacific Rim with a focus on North America, Latin America, as well as Asia.

Portfolio Companies of Paradigm Resource Management include Toss Plasma Technologies Ltd. (TPT). TPT has successfully developed the RF (Radio Frequency) plasma torch technology and mass production system using high power RF Plasma technology to extract precious metals from complex ores. TRF Systems Corp. has been established and owned 51 percent by TRF in Japan and commenced installing the RF Plasma system. The ore material will be provided from China. The products will sell in Japan.

The RF Plasma can break other multiple metal oxide layers that block the precious metals, including Au, Ag and Pt from extracting into the solution, or burns off the organo-metallic contents, which may inhibit the precious metals to be absorbed by the carbon used in the manufacture process. This plasma treatment is an effective process to enhance the extraction of these precious metals. This is due to the plasma treatment’s high temperature.

Last Friday, Paradigm Resource Management announced that they signed an Amendment to the original Acquisition Agreement, filed on July 24, 2013, that now enables the Company the option to control Toss Plasma Technologies (TPT).

Mr. Ted Ozaki, Paradigm's Chief Executive Officer, stated "Since our initial transaction in July 2013, we have experienced an astonishing level of interest from a wide range of mining companies, as such our ability to gain controlling ownership in TPT was a major accomplishment advancing the Company's business model. Paradigm is now positioned to become a pioneer with a game changing technology capable of extracting precious metals from complex mining ores that are commonly found in many different locations world-wide, this improves the Company's ability to attract new potential institutional and individual investors." 

Paradigm Resource Management Corp. (PRDC), closed Friday's trading session at $0.735, even for the day, on 68,110 volume with 24 trades. The average volume for the last 60 days is 459 and the stock's 52-week low/high is $0.1055/$0.689.

Endeavor IP, Inc. (ENIP)

PennyStocks24, Lebed.biz, WILD BILL, Goldman Small Cap Research, and Pumps and Dumps reported recently on Endeavor IP, Inc. (ENIP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Half Moon Bay, California, Endeavor IP, Inc. is an intellectual property (IP) services and patent licensing company. The OTCQB-listed Company engages in the acquisition and licensing of IP. Endeavor combines investment strategy, technology and best practices in the monetization of patents. Their focus is on investors, inventors, as well as their patent partners. The Company only defends patents with the potential to yield highly successful results.

Endeavor IP offers a portfolio approach to IP investing that lessens risk and maximizes returns. The Company is technology agnostic and applies modern investment management techniques to the patent sector. Endeavor IP’s leadership team includes individual’s from science and law to financial analysis and technology. The Company believes in protecting and aggressively enforcing the IP rights of inventors.

In October, Endeavor IP announced that they entered into a license and settlement agreement with a leading communications provider in the energy industry. The announcement marks the fourth settlement and license agreement generated by the patent portfolio currently being enforced by Endeavor IP's wholly-owned subsidiary, Endeavor Meshtech, Inc.

In November, Endeavor IP announced that the Company was issued a Notice of Allowance from the United States Patent and Trademark Office (USPTO). The Notice of Allowance pertains to Endeavor IP’s wholly-owned subsidiary Endeavor MeshTech and the patent titled Wireless Communication Enabled Meter and Network. Endeavor MeshTech filed patent infringement lawsuits against four defendants’ to-date pertaining to their Wireless Communication Enabled Meter and Network patent. Endeavor IP continues to explore opportunities to forcefully prosecute their patent portfolio. The law firm representing Endeavor IP in the prosecution of this patent is Lowenstein Sandler LLP.

Mr. Cameron Gray, CEO of Endeavor IP, said, "We are very pleased with this addition to Endeavor MeshTech, Inc.'s patent portfolio. The portfolio has been licensed by four companies’ to-date and there are four pending patent infringement lawsuits against four additional companies. This Notice of Allowance increases the portfolios to two issued U.S. patents and one allowed U.S. patent, which we anticipate issuing in the coming months."

Endeavor IP, Inc. (ENIP), closed Monday's trading session at $0.60, down 4.00%, on 160,429 volume with 115 trades. The average volume for the last 60 days is 288,951 and the stock's 52-week low/high is $0.1993/$1.28.

InVivo Therapeutics Holdings Corp. (NVIV)

Real Pennies and TheStockAdvisors reported earlier on InVivo Therapeutics Holdings Corp. (NVIV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, InVivo Therapeutics Holdings Corp. is a pioneering biomaterials company with corporate headquarters in Cambridge, Massachusetts. The Company has unique technologies for drug delivery with a focus on treatment of spinal cord injuries. InVivo Therapeutics established in 2005 with proprietary technology co-invented by Robert Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital.

InVivo Therapeutics Holdings earned the David S. Apple Award in 2011 from the American Spinal Injury Association for the Company’s outstanding contribution to spinal cord injury medicine. Recently, InVivo confirmed that they expect that the clinical trial of their first investigational product, a degradable polymer scaffold designed to promote healing following acute spinal cord injury, will be ready to enroll patients in the first quarter of 2014.

The Company indicated that most work on the InVivo hydrogel product development programs has been temporarily suspended due to InVivo’s focus on the scaffold manufacturing initiative and a review of their portfolio. Because of this review, the Company has decided to focus their efforts more intently on strategic corporate partnerships that would create the greatest value for patients and shareholders regardless of therapeutic area. InVivo Therapeutics Holdings has entered into discussions with several prospective corporate partners based on this new business model. However, the Company says that it is premature at this time to estimate timelines or therapeutic areas.

In November, InVivo Therapeutics Holdings announced that Mr. Christopher McNulty was appointed as Vice President, Business Development. Mr. McNulty most recently served as Senior Director of Business Development at Repligen Corp., where his responsibilities included out-licensing programs for rare neurodegenerative diseases.

Today, InVivo announced that Mr. William D’Agostino has been promoted to Vice President, Manufacturing & Engineering and that Mr. Robert Ham has been promoted to Senior Director, Quality. These promotions are effective January 1, 2014.

InVivo Therapeutics Holdings Corp. (NVIV), closed Monday's trading session at $1.59, up 3.25%, on 114,903 volume with 147 trades. The average volume for the last 60 days is 241,619 and the stock's 52-week low/high is $0.94/$6.20.

United Health Products, Inc. (UEEC)

XplosiveStocks, CRWEWallStreet, CRWEFinance, and Stock Guru reported earlier on United Health Products, Inc. (UEEC), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, United Health Products, Inc. is a product development and solutions company. They are focusing their growth initiatives on the expanding wound-care industry and the disposable medical supplies markets. Epic Wound Care, Inc. is their principal operating subsidiary. Epic produces an innovative gauze product called HemoStyp™, which absorbs exudate, or fluids that have been discharged from blood vessels, through forming a gel-like substance upon contact. United Health Products is based in Westbury, New York.

The Company is centering on identifying additional emerging healthcare products and technologies, chiefly hemostatic, for strategic partnership or acquisition. United Health Products’ HemoStyp™ is a patented hemostatic gauze for the healthcare and wound care sectors. HemoStyp™ is a collagen-like natural substance derived from regenerated oxidized cellulose, which is all natural. The design of it is to address severe bleeding in wound care applications.

HemoStyp™ is FDA registered. It is specially formulated gauze. It will produce hemostasis almost immediately upon application to a cut or open wound. It contains no harmful chemicals, thrombin, or animal by-products. Moreover, it is easily removed from the wound with water or saline solution without compromising coagulation. HemoStyp’s™ inherent bacteriostatic properties are also effective for contaminated wounds where it is difficult to maintain a sterile field.

HemoStyp™ controls several kinds of bleeding. These include arterial, veinal, and capillary injuries; post dialysis treatment; nose bleeds; abrasions, lacerations, and major cuts; dental surgeries; and puncture wounds. United Health Products’ technology is marketed as HemoStyp™ Gauze. However, it is available to customers with customized private labeling.

United Health Products announced in September of this year that they received formal notification of allowance of their patent application from the U.S. Patent Office for their HemoStyp™.  The Company is pursuing additional applications and filings for their HemoStyp™ product line. They are also working on the commercialization of HemoStyp® to their target markets, including the dental and dialysis marketplace.

In October, United Health Products announced that they engaged two distributors, Nu Spectrum Solutions, LLC and Critical Health Products Ltd., to market and sell their proprietary and patented HemoStyp™ products. The exclusive agreements for specific markets include suggested initial stocking inventories and require yearly minimums.

United Health Products, Inc. (UEEC), closed Monday's trading session at $0.17, down 13.71%, on 597,839 volume with 71 trades. The average volume for the last 60 days is 198,640 and the stock's 52-week low/high is $0.032/$0.20.

GeoVax Labs, Inc. (GOVX)

IRGnews Alert, FeedBlitz, SmallCapVoice, M2 Communications, Standout Stocks, Stockpalooza, Stock Stars, and PennyTrader.com reported previously on GeoVax Labs, Inc. (GOVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GeoVax Labs, Inc. is a biotechnology company with corporate headquarters in Atlanta, Georgia. The Company is developing vaccines to prevent and treat (Human Immunodeficiency Virus) HIV/AIDS. The Company’s mission includes developing AIDS vaccines for worldwide markets, manufacturing and testing these vaccines following Food and Drug Administration (FDA) guidelines, conducting human trials for vaccine safety and effectiveness, and ultimately obtaining regulatory approval of these vaccines in the U.S. and select global markets. GeoVax Labs’ shares trade on the OTC Markets’ OTCQB.

Clinical trials for the Company’s preventive HIV vaccines have been conducted by the US National Institutes of Health-supported HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Disease (NIAID).

GeoVax Labs has a unique, two component vaccine. It is a recombinant DNA and a recombinant modified vaccinia Ankara (MVA) The design of the vaccine is to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax Lab's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus (Gag, Pol, and Env).  In addition, both the DNA and MVA produce non-infectious virus-like-particles.  

The Company’s vaccines are unique in expressing virus-like particles that display the trimeric membrane-bound form of the HIV-1 envelope glycoprotein. At present, GeoVax vaccines are undergoing testing in human clinical trials, for both preventive and therapeutic applications.

In November, GeoVax Labs announced the appointment of Arban Domi, Ph.D., as the Company’s Director, Vector Development. Dr. Domi will be a vital player in the continued development of GeoVax Lab's HIV vaccines currently undergoing evaluation in human clinical trials. Dr. Domi will also be a key player in the development of versions of GeoVax’s vaccines for the subtypes of HIV affecting the developing world.

GeoVax Labs, Inc. (GOVX), closed Monday's trading session at $0.57, up 23.91%, on 720,838 volume with 183 trades. The average volume for the last 60 days is 33,867 and the stock's 52-week low/high is $0.355/$0.85.

Fresh Promise Foods, Inc. (FPFI)

Today we are reporting on Fresh Promise Foods, Inc. (FPFI), here at the QualityStocks Daily Newsletter.

Fresh Promise Foods, Inc., (formerly Stakool, Inc. (STKOD)), is a developer, processor, and marketer of healthy food products. The Company and their subsidiaries focus on three key strategic sectors: Food Processing, Water Management, and Consumer Products. Fresh Promise Foods’ shares trade on the OTC Markets’ OTCQB. The Company is based in Atlanta, Georgia.

On October 1, 2013, Stakool announced that they earlier approved a name change from Stakool, Inc. to Fresh Promise Foods, Inc., to better align with the Company's vision, mission, and values and their commitment to the development of leading edge brands and production processes for fresher, healthier foods. The expectation is that this category will reach $1 trillion globally by 2017.

Pertaining to Food Processing, Fresh Promise Foods’ Food Technology Group will engage in High Pressure Processing (HPP). It will be the foundation of all that the Company does. HPP is a method of food processing whereby food is subjected to elevated pressures (up to 87,000 pounds per square inch or approximately 6,000 atmospheres), with or without the addition of heat. This is to achieve microbial inactivation or to alter the food attributes to achieve consumer-desired qualities. Pressure inactivates most vegetative bacteria at pressures above 60,000 pounds per square inch.

HPP retains food quality, maintains natural freshness, as well as extends microbiological shelf life. HPP has shown to reduce bacteria such as Listeria, E.coli, and Salmonella in packaged refrigerated products as varied as ready-to-eat meats and raw ground beef and poultry; fresh fruits, juices, and smoothies; soups, wet salads, and sauces; and seafood and shellfish.

Fresh Promise Foods’ Consumer Products segment develops, manufactures, and supplies natural and organic food products packaged for consumer consumption in North America. The Company’s product line includes eight health bars. These bars have no refined sugar, no artificial flavors, low sodium, no genetically modified products, no preservatives, no trans-fat, no gluten, no cholesterol, no dairy products, and no wheat.

Fresh Promise Foods, Inc. (FPFI), closed Monday's trading session at $0.011, down 35.29%, on 548,097 volume with 16 trades. The average volume for the last 60 days is 141,463 and the stock's 52-week low/high is $0.01/$0.50.

Revolutionary Concepts, Inc. (REVO)

PennyStocks24, Pumps and Dumps, Jet-Life Penny Stocks, Pennystocktweeters.com, TryBestPennyStocks.biz, Whisper from Wall Street, and Otcstockexchange reported recently on Revolutionary Concepts, Inc. (REVO), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Revolutionary Concepts, Inc. focuses on the design and development of the EyeTalk Communicator. The Company is set to begin the launch and licensing of their patented technologies. On the whole, Revolutionary Concepts involves in the licensing and development of patented entry management systems, which interface with smart devices enabling remote monitoring and communication. The Company has invested in the Intellectual Property (IP) for several commanding wireless concepts enabling remote monitoring and efficient and effective security and entry management. Revolutionary concepts has their headquarters in Charlotte, North Carolina.

The Company’s EyeTalk Communicator will provide users the ability to remotely and interactively monitor, manage, and communicate through a smart camera designed to interface with IPhone, Androids, and other smart devices. The design of the system is to provide nationwide protection and monitoring of homes and businesses against multiple threats, such as robbery, fire, theft, burglary and other intrusions through mobile phones, wireless video, as well as remote smart camera security technology.

The Eye Talk Communicator serves as an entry management system. The design of EyeTalk is as primarily a smart camera technology supported by a software platform with a hardware component of an external unit deployed at a chosen location. The system's embedded processor will facilitate communication between the camera and the individual triggering its activation and/or the designated users of the system. The smart capabilities of the system will enable a live exchange between the end users and the person that triggered the camera or the camera will independently manage an activation on its own.

The Company currently has seven patents registered with the United States Patent and Trademark Office (USPTO), with others pending. Their first seven patents awarded regard an entry management system and give users the ability to remotely and interactively monitor by way of two-way communication and control an IP camera while using a personal communication device. Additional uses of their IP include medical applications and infant care technology.

Last week, Revolutionary Concepts announced that the Company has been in talks with one of the world's largest internet related service companies to sell or license their patented mobile product portfolio. Revolutionary Concepts has been in talks with a U.S. multinational corporation that specializes in Internet-related services and products and services.

Revolutionary Concepts, Inc. (REVO), closed Monday's trading session at $0.0052, up 52.94%, on 65,005,378 volume with 499 trades. The average volume for the last 60 days is 6,946,228 and the stock's 52-week low/high is $0.0009/$0.0132.

graphic

The QualityStocks
Company Corner

graphic
graphic

Blue Water Global Group, Inc. (BLUU)

The QualityStocks Daily Newsletter would like to spotlight Blue Water Global Group, Inc. (BLUU). Today, Blue Water Global Group, Inc. closed trading at $0.007, up 12.90%, on 223,740 volume with 11 trades. The stock’s average daily volume over the past 60 days is 317,336, and its 52-week low/high is $0.001/$0.036.

Blue Water Global Group, Inc. was announced today by QualityStocks as having a new and exclusive audio interview featuring BLUU president and CEO, J. Scott Sitra. The interview is now available online at http://www.qualitystocks.net/interview-bluu.php. In the interview Sitra goes over how BLUU is focused on developing a chain of restaurants throughout the Caribbean region under the Blue Water Bar & Grill™ brand, a restaurant concept that features a casual Caribbean themed atmosphere designed to provide a distinctive and relaxing island dining experience, in addition to which he the company's outlook and ongoing strategic equity investments in promising companies that are in the early stages of becoming publicly traded on the OTC Bulletin Board.

Blue Water Global Group, Inc. (BLUU) is focused on developing a chain of restaurants throughout the Caribbean region under the Blue Water Bar & Grill™ brand. In addition to its restaurant development activities, Blue Water is also engaged in making strategic equity investments in promising companies that are in the early stages of becoming publicly traded on the OTC Bulletin Board.

The Blue Water Bar & Grill™ restaurant concept features a casual Caribbean themed atmosphere designed to provide a distinctive and relaxing island dining experience. Each restaurant will have a large covered outside patio area where customers can enjoy their cuisine while overlooking a beautiful water view. The patio area will feature an inviting island styled bar and a small stage area for live musical performances by local musicians and dancing.

Expanding beyond the Blue Water Bar & Grill™ presently under development in St. Maarten, Dutch West Indies, the company aims to introduce its restaurant concept to other Caribbean islands. Management plans to open a new Blue Water Bar & Grill™ restaurant on each of the following islands in the next five years: Barbados; Aruba, Dutch West Indies; Cozumel, Mexico; Grand Cayman; and Nassau, Bahamas.

Additionally, through its strategic alliance agreement with Taurus Financial Partners, Blue Water has gained access to various financial consulting services and will be assisted with utilizing its status as a publicly traded company to conduct registered “spin-offs”. Each spin-off will be designed to reward loyal Blue Water shareholders with a dividend of the spin-off business’s stock while simultaneously enhancing Blue Water’s overall balance sheet. Disclaimer

Blue Water Global Group, Inc. Company Blog

Blue Water Global Group, Inc. News:

Blue Water Global Group, Inc. CEO Featured in Exclusive QualityStocks Interview

Blue Water Announces Significant Equity Investment

Blue Water Announces Its Stock is Now DTC DWAC/FAST Eligible

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.175, up 11.46%, on 1,732,082 volume with 412 trades. The stock’s average daily volume over the past 60 days is 706,703, and its 52-week low/high is $0.13/$0.41.

International Stem Cell Corp. today announced significant advancement in human induced pluripotent stem cells (iPS) derivation with a novel protein-based reprogramming method. ISCO's biologists have developed a fundamentally new method that both successfully enhances the efficiency of the reprogramming process using specific proteins called transducible transcription factors (TTF) and avoids the use of viruses, with ISCO having now shown that this TTF-iPS technology can produce stable stem cells, is at least ten times more efficient that older methods, and it simultaneously avoids the risks associated with traditional methods based on viruses.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Major Advance in Stem Cell Technology

International Stem Cell Corp. CEO Featured in Exclusive QualityStocks Interview

International Stem Cell Corp. Featured in Exclusive QualityStocks Video Production

OBJ Enterprises, Inc. (OBJE)

The QualityStocks Daily Newsletter would like to spotlight OBJ Enterprises, Inc. (OBJE). Today, OBJ Enterprises, Inc. closed trading at $0.35, up 6.06%, on 154,111 volume with 54 trades. The stock’s average daily volume over the past 60 days is 135,282, and its 52-week low/high is $0.25/$3.90.

OBJ Enterprises, Inc. reached a new milestone in the development of its Creature Tavern app this week when the game was submitted for inclusion on both the Apple App Store and Google Play networks. Developed by OBJE’s in-house creative firm Novalon Games, Creature Tavern has been designed to give the company a bright, bold presence in an explosive, global gaming marketplace and hits stores at an ideal time, as a survey commissioned by PBS Kids recently found that 54% of parents say they plan to purchase or give a tech gift to their children this holiday season, with tablets and video game consoles topping the list.

OBJ Enterprises, Inc. (OBJE) utilizes a powerful joint-venture partnership model to work alongside industry experts and universities to develop educational and popular gaming applications for the digital gaming market, the fastest-growing segment of the global IT industry. The company’s operating subsidiary, Obscene Interactive, is focused on developing innovative social gaming solutions to capitalize on the burgeoning mobile app marketplace, as well as the latest advances in media distribution platforms and advertising placement within apps.

The global gaming industry is predicted to top $66 billion in 2014. As global demand for engaging new gaming content grows with advancements in technology, OBJ Enterprises is pursuing acquisitions of emerging game development companies with portfolios of progressive technology assets such as cloud computing, discrete product placement, and micro-transactions to capitalize on the explosion in console, smartphone, and tablet usage across the globe.

Leveraging innovative and proactive partners who share the company’s vision to create next-generation digital games, OBJ Enterprises has demonstrated its invaluable ability to identify both current gaming trends and keep pace with the industry’s constant evolution. The company is constantly working on new ways to capitalize on emerging gaming trends such as biometric applications - using electronic measurement of unique human characteristics such as fingerprints and irises –for medically themed games, social games, horror games, and more.

Spearheading these growth initiatives is OBJ Enterprises CEO Paul Watson, who has domestic and international experience in fundraising for startups, growth capital, business development, and venture finance. Under his leadership and backed by a team of highly experienced management, OBJ Enterprises plans to advance its gaming portfolio to include applications in health, safety, educational, corporate, and software training. Disclaimer

OBJ Enterprises, Inc. Company Blog

OBJ Enterprises, Inc. News:

OBJE's Revenues Set to Grow With New Game

OBJE Poised for Explosion in Holiday App Downloads

OBJE Negotiates New Game Licensing and Development Agreement

Kallo, Inc. (KALO)

The QualityStocks Daily Newsletter would like to spotlight Kallo, Inc. (KALO). Today, Kallo, Inc. closed trading at $0.04, up 5.26%, on 20,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 29,935, and its 52-week low/high is $0.012/$0.055.

Kallo, Inc. was announced today by The Minister of Health and Public Hygiene, his Excellency Doctor Edouard Niankoye Lama, regarding Guinea's move to implement a unique healthcare delivery program aimed at bringing a higher standard of healthcare to its rural population and accelerating the progress towards Guinea's healthcare Millennium Development Goals. A blended program of MobileCare and RuralCare from Kallo Inc. is expected to commence implementation in the first quarter of 2014 and over the following 24 months Mobile Clinics, Polyclinics, Utility Vehicles and Ambulances will provide medical services locally to the people of Guinea.

Kallo, Inc. (KALO) leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare industry. Offering centralized, congruent solutions that attend healthcare and business issues, the company addresses the needs of hospitals, ministries of health, physicians, and other healthcare organizations.

As a result of an expanding and aging population, coupled with an increasing number of people suffering from chronic diseases and lifestyle related conditions, healthcare expenditures continue to grow. Kallo is focused on introducing new healthcare technology that helps contain costs, enable better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

The tailored solutions offered by Kallo complement existing infrastructure, workflows, and processes, increasing both uptime and productivity. The company’s suite of products complies with international, national, and regional standards, and its stringent quality control ensures repeatable, process-driven delivery for maximum performance.

Kallo’s executives and directors bring rich and diverse industry knowledge. Collectively, the management team reflects the strength of the company’s global network and the diversity of its global culture. The team’s entrepreneurship, passion, experience, and knowledge of healthcare enables Kallo to continually deliver higher standards. Disclaimer

Kallo, Inc. Company Blog

Kallo, Inc. News:

Republic of Guinea Will Start Implementation of Kallo MobileCare & RuralCare in Q1-2014

Kallo, Inc. Announces Engagement of QualityStocks Investor Relations Services

Kallo to Negotiate Implementation Strategy of MobileCare(TM) With Guinea Government Officials

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.09, up 28.57%, on 51,000 volume with 8 trades. The stock’s average daily volume over the past 60 days is 33,550, and its 52-week low/high is $0.03/$0.15.

Global Payout, Inc. (GOHE) specializes in customized payment solutions for businesses and organizations worldwide. The company’s global network of banks and processing partners enable companies and organizations to efficiently deploy a customized payment solution configured specifically for each client. From solving a single payment issue to meeting an entire global payment requirement, Global Payout in conjunction with its partners delivers modular payment solutions.

Global Payout has a product line of prepaid "off the shelf" products that can be utilized or Global Payout can customize payment solutions for qualified businesses. By coupling its network of international banks and third-party processing relationships with an innovative payment platform, Global Payout enables organizations to "plug into" an efficient and cost effective method of paying employees, contractors, investors, and commissioned agents wherever they might be located in the world.

Global Payout began operations as a business to business provider of pre-paid debit cards for payroll and general spend programs. The company then launched a Prepaid Discover® card to meet the demand of its business clients in the United States. As a result of these efforts and with the input of their client base, Global Payout then greatly extended its reach by developing a new proprietary “payment platform” which enables companies and organizations to make necessary payments in every country a company does business. Clients can now make international payments without the need to establish banking relationships in each and every country they do business. Businesses now have an efficient, compliant and simplified system to make their all necessary international payments using Global Payout’s proprietary payment platform.

Global Payout delivers dependable and secure global payment solutions for companies worldwide. This relieves clients of burdensome and time consuming efforts to establish banking relationships everywhere they do business. The company’s “consolidated payment gateway” product can be configured specifically to the needs of each client within a short period of time. Global Payout is led by a management team comprised of pioneers in domestic and international payment delivery solutions. The company is well positioned to leverage their long standing international financial relationships to expand their services and global reach. Even during this expansion, Global Payout remains committed to serving domestic and international clients and providing them with customized one-stop solutions that address each client’s specific payment needs. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. CEO Featured in Exclusive QualityStocks Interview

Global Payout, Inc. Announces Engagement of QualityStocks Investor Relations Services

ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway

Victory Energy Corp. (VYEY)

The QualityStocks Daily Newsletter would like to spotlight Victory Energy Corp. (VYEY). Today, Victory Energy Corp. closed trading at $0.25, up 66.67%, on 200 volume with 2 trades. The stock’s average daily volume over the past 60 days is 2,093, and its 52-week low/high is $0.0136/$0.40.

Victory Energy Corp. (VYEY) is an independent, growth-oriented oil and gas company focused on growing proved reserves and cash-flow via the continued development of existing properties and the acquisition of new resource properties, primary located in the prolific Permian Basin of Texas and southeast New Mexico. The Company will source new capital to facilitate this growth by continuing to utilize an established pipeline of investors available through Aurora Energy Partners and additional third-party sources. The company is committed to creating long-term shareholder value by increasing oil reserves, lowering costs, boosting production volumes, and prudently managing the capital on its balance sheet.

The company is geographically focused onshore, with a primary emphasis on the Permian Basin of Texas and southeast New Mexico. Victory strategically utilizes both internal capabilities and strategic industry relationships to acquire non-operated working interest positions in low-to-moderate risk oil and gas prospects. Its focus is on oil or liquid-rich gas projects within longer-life reservoirs that offer competitive finding and development (F&D) costs per barrel of oil equivalent (BOE).

Victory’s carefully assembled management team has more than 120 years of direct and relevant oil and gas experience. The company also utilizes a team of third-party professionals on an as-needed basis. This team includes geologists for property evaluation and assessment and reservoir engineering resources for the analysis of current and new properties. Reserve reporting is performed by a third-party engineer located in Midland, Texas. Each independent operator utilized by the company also has their own array of experts.

As it executes its strategy, Victory will be targeting investment in larger working interest projects (10%-25% that are weighted toward oil and high-BTU natural gas. This approach of increasing economic interest should allow for improved returns through cost efficiencies derived from economies of scale. Lower expenses and additional capital will give the company added flexibility to invest in the development of its current proven undeveloped, possible, and probable reserves, while also allowing for additional oil and gas prospects and improved working interest positions. Disclaimer

Victory Energy Corp. Company Blog

Victory Energy Corp. News:

Victory Energy Engages Weaver as Auditor

Victory Energy Corporation Doubles in Size

Victory Energy Appoints New Board Member

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.20, up 25.00%, on 43,655 volume with 9 trades. The stock’s average daily volume over the past 60 days is 26,030, and its 52-week low/high is $0.07/$0.70.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Mabwe Minerals and WGB Kinsey Close Equity Exchange Agreement

Mabwe Minerals Letter to Shareholders: Part II

Mabwe Minerals Issues Letter to Shareholders

Innocent, Inc. (INCT)

The QualityStocks Daily Newsletter would like to spotlight Innocent, Inc. (INCT). Today, Innocent, Inc. closed trading at $0.075, up 8.70%, on 1,188,936 volume with 44 trades. The stock’s average daily volume over the past 60 days is 81,157, and its 52-week low/high is $0.001/$0.092.

Innocent, Inc. (INCT) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Innocent aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Innocent has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Innocent is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Innocent, Inc. Company Blog

Innocent, Inc. News:

Innocent Inc. Announces Letter to Shareholders

Innocent Inc. Announces New Joint Venture to Explore for Oil and Gas

Innocent, Inc. (INCT) is "One to Watch"

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(TGRO)

2.

Wallstreetlivechat
(REVO)

3.

PennyStocks24
(LIBE)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251